End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25 CAD | +1.46% | +0.36% | +10.28% |
06-28 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
06-28 | AbbVie, Genmab Receive Positive European Opinion on Marketing Authorization for Possible Lymphoma Treatment | MT |
Chart calendar AbbVie Inc.
Upcoming events on AbbVie Inc.
Past events on AbbVie Inc.
12/06/2024 15:00 | Goldman Sachs Global Healthcare Conference |
03/06/2024 20:15 | American Society of Clinical Oncology Meeting - Abstract No: 3515 |
02/06/2024 16:01 | American Society of Clinical Oncology Meeting - Abstract No: 103 |
01/06/2024 21:12 | American Society of Clinical Oncology Meeting - Abstract No: 3001 |
15/05/2024 18:40 | BofA Securities Health Care Conference |
03/05/2024 15:00 | Annual General Meeting |
26/04/2024 14:00 | Q1 2024 Earnings Call |
26/04/2024 12:35 | Q1 2024 Earnings Release |
11/04/2024 | Détachement de |
27/03/2024 15:30 | Anti-Aging and Aesthetics Medicine World Congress |
27/03/2024 13:00 | Anti-Aging and Aesthetics Medicine World Congress |
27/03/2024 10:15 | Anti-Aging and Aesthetics Medicine World Congress |
27/03/2024 08:45 | Anti-Aging and Aesthetics Medicine World Congress |
14/03/2024 13:00 | Barclays Global Healthcare Conference |
10/03/2024 21:45 | American Academy of Dermatology Meeting |
10/03/2024 21:40 | American Academy of Dermatology Meeting |
10/03/2024 21:30 | American Academy of Dermatology Meeting |
09/03/2024 23:30 | American Academy of Dermatology Meeting |
09/03/2024 23:10 | American Academy of Dermatology Meeting |
09/03/2024 23:00 | American Academy of Dermatology Meeting |
Past dividends on AbbVie Inc.
11/04/2024 | Quarterly 1.55 USD |
11/01/2024 | Quarterly 1.55 USD |
11/10/2023 | Quarterly 1.48 USD |
12/07/2023 | Quarterly 1.48 USD |
12/04/2023 | Quarterly 1.48 USD |
11/01/2023 | Quarterly 1.48 USD |
12/10/2022 | Quarterly 1.41 USD |
13/07/2022 | Quarterly 1.41 USD |
12/04/2022 | Quarterly 1.41 USD |
12/01/2022 | Quarterly 1.41 USD |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 33 266 33 255 0.03% | 45 784 45 637 0.32% | 56 122 56 238 -0.21% | 58 054 58 284 -0.4% | 54 318 54 047 0.5% | 55 199 |
EBITDA Million USD | Released Forecast Spread | 17 747 16 811 5.57% | 22 642 22 766 -0.54% | 29 018 29 168 -0.51% | 30 961 31 181 -0.7% | 25 545 25 858 -1.21% | 26 357 |
EBIT Million USD | Released Forecast Spread | 15 730 15 736 -0.04% | 21 976 21 832 0.66% | 28 215 28 167 0.17% | 30 183 30 154 0.1% | 24 793 24 926 -0.53% | 25 594 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 8 426 12 085 -30.28% | 3 398 14 347 -76.32% | 12 989 12 579 3.26% | 13 477 16 796 -19.76% | 6 250 8 933 -30.04% | 12 004 |
Net income Million USD | Released Forecast Spread | 7 882 7 753 1.66% | 4 616 7 357 -37.26% | 11 542 11 140 3.61% | 11 836 14 494 -18.34% | 4 863 8 288 -41.32% | 8 604 |
EPS USD | Released Forecast Spread | 5,28 5,23 0.97% | 2,72 4,27 -36.28% | 6,45 6,25 3.27% | 6,63 8,28 -19.89% | 2,72 5,30 -48.69% | 5,73 |
Announcement Date | 07/02/20 | 03/02/21 | 02/02/22 | 09/02/23 | 02/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 13 538 13 613 -0.55% | 14 583 14 640 -0.39% | 14 812 14 944 -0.89% | 15 121 15 337 -1.41% | 12 225 12 230 -0.04% | 13 865 13 520 2.55% | 13 927 13 707 1.6% | 14 301 14 027 1.96% | 12 310 11 936 3.14% | 14 016 | 14 196 | 14 729 | 13 208 | 14 374 |
EBITDA Million USD | Released Forecast Spread | 7 156 7 115 0.58% | 7 643 8 083 -5.45% | 8 090 8 645 -6.42% | 8 072 8 405 -3.96% | 5 682 5 686 -0.06% | 6 710 6 633 1.16% | 6 706 6 681 0.37% | 6 447 6 600 -2.32% | 5 444 | 7 100 | 6 877 | 7 049 | ||
EBIT Million USD | Released Forecast Spread | 6 958 6 972 -0.21% | 7 440 7 382 0.78% | 7 909 7 843 0.85% | 7 876 7 778 1.26% | 5 503 5 553 -0.9% | 6 520 6 398 1.9% | 6 510 6 498 0.19% | 6 260 6 391 -2.05% | 5 195 5 158 0.71% | 6 899 | 6 721 | 6 826 | 6 631 | 7 053 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 475 5 059 -90.61% | 2 610 3 685 -29.17% | 1 953 3 960 -50.68% | 1 212 3 839 -68.43% | 1 755 2 367 -25.86% | 3 504 | 3 346 | 3 397 | ||||||
Net income Million USD | Released Forecast Spread | 4 490 3 473 29.3% | 924 4 067 -77.28% | 3 949 5 207 -24.16% | 2 473 3 781 -34.59% | 239 2 405 -90.06% | 2 024 2 570 -21.25% | 1 778 2 937 -39.46% | 822 1 580 -47.98% | 1 369 1 220 12.17% | 2 643 | 2 437 | 2 393 | 2 477 | 2 834 |
EPS USD | Released Forecast Spread | 2,51 2,03 23.44% | 0,51 2,13 -76.06% | 2,21 2,87 -22.91% | 1,38 2,71 -49.14% | 0,13 1,42 -90.82% | 1,14 1,43 -20.46% | 1,00 1,72 -41.86% | 0,46 2,00 -76.95% | 0,77 0,66 16.08% | 1,80 | 1,58 | 1,67 | 1,39 | 1,59 |
Announcement Date | 29/04/22 | 29/07/22 | 28/10/22 | 09/02/23 | 27/04/23 | 27/07/23 | 27/10/23 | 02/02/24 | 26/04/24 | - | - | - | - | - |
Past sector events for AbbVie Inc.
21/06/2024 16:28 | DEVA HOLDING: Q1 2024 Earnings Release |
13/06/2024 22:21 | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
11/06/2024 06:30 | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
07/06/2024 11:33 | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
07/06/2024 10:17 | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
30/05/2024 13:08 | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
30/05/2024 12:00 | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
30/05/2024 07:24 | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
29/05/2024 13:00 | FDC LIMITED: Q4 2024 Earnings Release |
29/05/2024 10:26 | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ABBV Stock
- ABBV Stock
- Calendar AbbVie Inc.